Jason M. Broderick

The FDA has approved lenalidomide (Revlimid) plus dexamethasone in newly diagnosed patients with multiple myeloma based on findings from the phase III FIRST trial.

A "co-rounding" model partnering medical oncologists with palliative care specialists was associated with improved outcomes at an inpatient oncology unit, according to a retrospective cohort analysis presented at a presscast ahead of the 2014 Palliative Care in Oncology Symposium.

Patients who are uninsured, nonwhite, less educated, poorer, not married, older, male, or have advanced-stage cancer have a higher mortality risk within 1 month of cancer surgery

Two recently published clinical studies demonstrated a strong association between higher levels of vitamin D and improved outcomes among patients with various cancers.

Despite evidence supporting its efficacy, chemotherapy is not routinely administered to patients with muscle-invasive bladder cancer (MIBC)

Phase III trial results presented at the 2014 ASCO Annual Meeting showed that the dosing frequency of zoledronic acid (Zometa) can be reduced by 67% without compromising effectiveness in women with breast cancer and bone metastases, potentially lowering the risk of serious adverse events.

Antiresorptive medicines used to reduce the loss of bone mass related to bone metastases or treatment toxicity are associated with an increased risk of ONJ.

Awareness and treatment of oncofertility have been given a tremendous boost over the past 5 years by the Oncofertility Consortium.

At NCONN 2011, Sean Grimm, MD, discussed the management of Glioblastoma multiforme, the most common malignant primary brain tumor.

Honorary Mistress of Ceremonies Cynthia Nixon kicked off the festivities for the 2011 CURE magazine Extraordinary Healer Award.

Singer and songwriter Charlie Lustman has become an inspirational voice for the over 12 million cancer survivors living in the United States

OncLive Nursing discusses highprofile patients with Barron H. Lerner, MD, PhD, author of When Illness Goes Public: Celebrity Patients and How We Look at Medicine

Celebrity advocacy takes the form of both individual crusades and collaborative efforts, such as Stand Up To Cancer (SU2C)

The National Cancer Institute (NCI) estimates that sexual dysfunction rates among cancer survivors range anywhere between 40% and 100%

At NCONN 2010, Matthew Zachary, musician, brain cancer survivor, and founder of the I'm Too Young For This! Cancer Foundation (i[2]y) discussed empowering young adults with cancer.